BG Medicine, Inc.

Definitive Proxy Statement

Certification of termination of registration of a class of securities (Section 12(b))

No description available

Annual report pursuant to Section 13 or 15(d) (amendment)

Annual report pursuant to Section 13 or 15(d)

Notification of late filing of Form 10-K

2.02,8.01

Notice of Effectiveness

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post-effective amendment to a registration statement

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

5.02

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

8.01,9.01

4.01,9.01

1.01,9.01

Notification of removal from listing and/or registration on a national securities exchange (amendment)

Notification of removal from listing and/or registration on a national securities exchange

3.01

5.02,9.01

2.02,8.01,9.01

General form for quarterly reports under Section 13 or 15(d)

5.02

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

No description available

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

General form for quarterly reports under Section 13 or 15(d) (amendment)

8.01,9.01

1.01,5.03,8.01,9.01

General form for quarterly reports under Section 13 or 15(d) (amendment)

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

Entry into a Material Definitive Agreement

8.01,9.01

Submission of Matters to a Vote of Security Holders

8.01,9.01

8.01

1.01,2.03,3.02,5.02,9.01

Definitive Proxy Statement

Prospectus Supplement for Delayed or Continuous Offering

Notice of Effectiveness

Letter from the SEC

Correspondence with the SEC

06b

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933

General form for quarterly reports under Section 13 or 15(d)

2.02,8.01,9.01

Preliminary Proxy Statement

Annual report pursuant to Section 13 or 15(d) (amendment)

Annual report pursuant to Section 13 or 15(d)

Prospectus Supplement for Primary Offering

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Prospectus Supplement for Primary Offering

General form for quarterly reports under Section 13 or 15(d)

Additional Information for Proxy Statement/ Votes

Required Information in Proxy Statement

Definitive Proxy Statement

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

No description available

General form for quarterly reports under Section 13 or 15(d) (amendment)

Definitive Proxy Statement

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Definitive Proxy Statement

No description available

No description available

No description available

No description available

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Seawell Haygood Paterson Sr

Adourian Aram S.

HALL STEPHEN P

Adourian Aram S.

Adourian Aram S.

HALL STEPHEN P

SOHMER PAUL R

LUBER JEFFREY R

LUBER JEFFREY R

AFEYAN NOUBAR

PAPADOPOULOS STELIOS

OCONNOR JAMES F O

AFEYAN NOUBAR

WILCOX HARRY W

Adourian Aram S.

SOHMER PAUL R

HALL STEPHEN P